1. Familial Haploidentical (FHI) T-Cell Depleted (TCD) with T-Cell Addback Stem Cell Transplantation for Patients with High-Risk Sickle Cell Disease (SCD) (IND 14359) 
Julie-An M. Talano, Cori Abikoff, Carolyn A. Keever-Taylor, Mark C. Walters, Shalini Shenoy, Theodore B. Moore, Susan K. Parsons, Allen J. Dozor, Deborah Friedman, Qiuhu Shi, Suzanne Braniecki, Brenda Grossman, Rona Weinberg, Erin Morris, Phyllis Brand, Sandra Fabricatore, Janet Ayello, Mildred Semidei-Pomales, Lee Ann Baxter-Lowe, Mitchell S. Cairo 
Biology of Blood and Marrow Transplantation 
Volume 23, Issue 3, Pages S246-S247 (March 2017)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1
(A) Probability of AGVHD: 15 evaluable patients; 7.1% (CI95:0-69.0). (B) Probability of CGVHD 15 evaluable patients; 23.07% (CI95: ).
Biology of Blood and Marrow Transplantation  , S246-S247DOI: ( /j.bbmt )
Copyright © Terms and Conditions

3. Figure 2 Probability 1-year survival n = 18; 87.4% (CI95: 58.1-96.7).
Biology of Blood and Marrow Transplantation  , S246-S247DOI: ( /j.bbmt )
Copyright © Terms and Conditions